Page last updated: 2024-11-07

daidzin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Daidzin is a naturally occurring isoflavone glycoside found in soybeans, which is a precursor to daidzein. It is synthesized through the shikimate pathway, where phenylalanine is converted to daidzein. Daidzin is known for its potential health benefits, including antioxidant, anti-inflammatory, and estrogenic properties. It is studied for its potential effects on bone health, cardiovascular disease, and cancer prevention. Daidzin's importance lies in its role as a bioactive compound in soy-based foods and its potential applications in nutraceuticals and pharmaceuticals.'

daidzin: a potent, selective, and reversible inhibitor of human mitochondrial aldehyde dehydrogenase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

daidzein 7-O-beta-D-glucoside : A glycosyloxyisoflavone that is daidzein attached to a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. It is used in the treatment of alcohol dependency (antidipsotropic). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID107971
CHEMBL ID486422
CHEBI ID42202
SCHEMBL ID315373
MeSH IDM0062041

Synonyms (69)

Synonym
BIDD:ER0154
daidzein-7-glucoside
brn 0059741
ACON1_002092
MEGXP0_000530
NCGC00179839-01
552-66-9
daidzin
daidzein 7-o-glucoside
DZN ,
7-(beta-d-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
daidzein 7-o-beta-d-glucoside
CHEBI:42202 ,
3-(4-hydroxyphenyl)-7-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
daidzein 7-glucoside
daidzoside
DB02115
7-(beta-d-glucopyranosyloxy)-3-(4-hydroxyphenyl)-4h-chromen-4-one
7-o-glucosyl-4'-hydroxyisoflavone
daidzin, >=95.0% (hplc)
2VLE
CHEMBL486422
dadzin
3-(4-hydroxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
NCGC00163532-03
NCGC00163532-02
A830561
bdbm50409029
4-18-00-01808 (beilstein handbook reference)
npi 031d
4r2x91a5m5 ,
unii-4r2x91a5m5
daidzein 7-o-.beta.-d-glucoside
daidzin [usp-rs]
daidzein daidzin [mi]
daidzin (constituent of soy isoflavones) [dsc]
daidzin (constituent of astragalus) [dsc]
CCG-208383
SCHEMBL315373
KYQZWONCHDNPDP-QNDFHXLGSA-N
MLS006010640
smr001833087
CS-4237
daidzein-7-o-glucoside
Q-100628
3-(4-hydroxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
HY-N0018
mfcd00017466
npi-031d
daidzin, analytical standard
daidzin, primary pharmaceutical reference standard
daidzin, united states pharmacopeia (usp) reference standard
4',7-dihydroxyisoflavone 7-o-b-d-glucopyranoside
daidzein 7-o-beta-d-glucopyranoside
3-(4-hydroxyphenyl)-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
4',7-dihydroxyisoflavone; 7-o-b-d-glucopyranoside
3-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl beta-d-glucopyranoside
Q3814656
AS-35078
daidzein 7-o-|a-d-glucopyranoside
STL565871
7-o-beta-d-glucopyranoside
7,4'-dihydroxyisoflavone 7-glucoside
DTXSID00862180
daidzein daidzin
daidzin (constituent of soy isoflavones)
3-(4-hydroxyphenyl)-4-oxo-4h-1-benzopyran-7-yl beta-d-glucopyranoside
daidzin (constituent of astragalus)
daidzin (usp-rs)

Research Excerpts

Overview

Daidzin (DDZ) is a natural brassin-like compound extracted from the soybean. It has been found to have therapeutic potential against tumors in recent years.

ExcerptReferenceRelevance
"Daidzin (DDZ) is a natural brassin-like compound extracted from the soybean, and has been found to have therapeutic potential against tumors in recent years. "( Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1.
Li, L; Liu, X; Qu, L; Xu, H; Xu, K, 2022
)
3.61
"Daidzin is a potent, selective, and reversible inhibitor of human mitochondrial aldehyde dehydrogenase (ALDH) that suppresses free-choice ethanol intake by Syrian golden hamsters. "( Daidzin suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism.
Keung, WM; Kunze, L; Lazo, O; Vallee, BL, 1995
)
3.18

Actions

Daidzin does not inhibit human class I, II, or III alcohol dehydrogenases, nor does it have any significant effect on biological systems. Daidzin analogs that suppress hamster ethanol intake also inhibit 5-HIAA and DOPAC formation.

ExcerptReferenceRelevance
"Daidzin does not inhibit human class I, II, or III alcohol dehydrogenases, nor does it have any significant effect on biological systems that are known to be affected by other isoflavones."( Daidzin: a potent, selective inhibitor of human mitochondrial aldehyde dehydrogenase.
Keung, WM; Vallee, BL, 1993
)
2.45
"Daidzin analogs that suppress hamster ethanol intake also inhibit 5-HIAA and DOPAC formation."( Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria.
Keung, WM; Vallee, BL, 1998
)
2.46

Treatment

Daidzin pretreatment attenuated the swollen mitochondria observed in the d-GalN/LPS group. Pretreatment with daidzin remarkably reduced the severity of epileptogenesis in a dose-dependent manner.

ExcerptReferenceRelevance
"The daidzin pretreatment attenuated the swollen mitochondria observed in the d-GalN/LPS group."( Protective effect of daidzin against D-galactosamine and lipopolysaccharide-induced hepatic failure in mice.
Choi, JS; Heo, JH; Kang, SS; Kim, SH; Kim, YS; Lee, SM, 2009
)
1.15
"Daidzin treatment (150 mg/kg per day i.p."( Daidzin suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism.
Keung, WM; Kunze, L; Lazo, O; Vallee, BL, 1995
)
2.46
"Pretreatment with daidzin remarkably reduced the severity of epileptogenesis in a dose-dependent manner."( Anti-epileptic activity of daidzin in PTZ-induced mice model by targeting oxidative stress and BDNF/VEGF signaling.
Kazmi, Z; Khan, A; Khan, S; Malik, S; Seo, EK; Shehzad, A; Zeeshan, S, 2020
)
1.18

Pharmacokinetics

ExcerptReferenceRelevance
"To clarify the role of the intestinal flora in the absorption and metabolism of mangiferin and to elucidate its metabolic fate and pharmacokinetic profile in diabetic rats, a systematic and comparative investigation of the metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin (STZ)-induced diabetic rats was conducted."( Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats.
Chen, M; Fan, M; He, L; Huang, C; Jian, L; Li, Z; Liu, H; Pan, G; Wang, K; Wu, B, 2012
)
0.38
" The study investigated the pharmacokinetic behavior of puerarin-7-O-glucuronide (without enzymatic hydrolysis), puerarin and daidzin when total flavonoid from Gegen was administered in normal and blood stasis animals or in blood stasis animals alone or in combination with Sanqi."( Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiologica
Gao, E; Liu, X; Liu, Z; Yu, Z; Zhao, X; Zhao, Y, 2013
)
0.86
" The validated method was successfully applied to pharmacokinetic study of the seven components in female rat plasma after oral administration of Ge-Gen Decoction aqueous extract."( Simultaneous determination of puerarin, daidzin, daidzein, paeoniflorin, albiflorin, liquiritin and liquiritigenin in rat plasma and its application to a pharmacokinetic study of Ge-Gen Decoction by a liquid chromatography-electrospray ionization-tandem m
Chai, CZ; Huo, LX; Wang, DW; Wu, J; Xiao, HH; Yan, Y; Yu, BY; Zhu, DN, 2014
)
0.67
" FQ-PCR assays of rabbits' vertebrobasilar arterial tissue were performed to determine the pharmacodynamic profiles of the four GGDs."( Relevance of the Pharmacokinetic and Pharmacodynamic Profiles of Puerariae lobatae Radix to Aggregation of Multi-Component Molecules in Aqueous Decoctions.
Hu, J; Kan, Y; Pang, W; Su, B; Xie, J, 2016
)
0.43
" These results support the potential of this method for successful application in pharmacokinetic studies."( Metabolite Identification and Pharmacokinetic Profiling of Isoflavones from Black Soybean in Rats Using Ultrahigh-Performance Liquid Chromatography with Linear-Ion-Trap-Orbitrap and Triple-Quadrupole Tandem Mass Spectrometry.
Bai, J; Guo, Q; Huang, J; Liu, Y; Qiu, X; Su, Z; Wei, M; Zhang, J, 2018
)
0.48

Compound-Compound Interactions

ExcerptReferenceRelevance
" The study investigated the pharmacokinetic behavior of puerarin-7-O-glucuronide (without enzymatic hydrolysis), puerarin and daidzin when total flavonoid from Gegen was administered in normal and blood stasis animals or in blood stasis animals alone or in combination with Sanqi."( Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiologica
Gao, E; Liu, X; Liu, Z; Yu, Z; Zhao, X; Zhao, Y, 2013
)
0.86
"The crude methanol extract of Pueraria lobata was investigated by dual high-resolution α-glucosidase inhibition and radical scavenging profiling combined with hyphenated HPLC-HRMS-SPE-NMR."( Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
Jäger, AK; Kongstad, KT; Liu, B; Nyberg, NT; Qinglei, S; Staerk, D, 2015
)
0.42

Bioavailability

Daidzin is an isoflavone glycoside with estrogenic activities. The crude extract daidzin has approximately 10 times greater bioavailability than the pure compound. A liquid chromatography-tandem mass spectrometry procedure was used to investigate the metabolism and bioavailability of puerarin and Daidzin.

ExcerptReferenceRelevance
"injection indicate that the crude extract daidzin has approximately 10 times greater bioavailability than the pure compound."( Potentiation of the bioavailability of daidzin by an extract of Radix puerariae.
Keung, WM; Kunze, L; Lazo, O; Vallee, BL, 1996
)
0.83
" A liquid chromatography-tandem mass spectrometry procedure was used to investigate the metabolism and bioavailability of puerarin and daidzin."( Contrasting effects of puerarin and daidzin on glucose homeostasis in mice.
Barnes, S; Jones, K; Meezan, E; Meezan, EM; Moore, R; Prasain, JK, 2005
)
0.81
" These results suggest that selected probiotic strains of Bifidobacterium can be used to speed up the release of daidzein, improving its bioavailability for absorption by colonic mucosa and/or biotransformation to S-equol by other intestinal microorganisms."( Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains.
Amaretti, A; De Lucia, M; Leonardi, A; Pagnoni, UM; Raimondi, S; Roncaglia, L; Rossi, M, 2009
)
0.63
" However, these studies cannot reflect the realistic effects that soy may induce through diets, and little is known about the bioavailability of isoflavones from whole soy food and their bioactivities after cooking and digestion."( Apoptotic effects of cooked and in vitro digested soy on human prostate cancer cells.
Dong, X; Sikes, RA; Wu, C; Xu, W, 2012
)
0.38
"A novel drug delivery system, TPGS 1000 (TPGS) emulsified zein nanoparticles (TZN), were designed with an objective to improve the oral bioavailability of daidzin, an isoflavone glycoside with estrogenic activities."( TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: in vitro characteristics and in vivo performance.
Gu, L; Zou, T, 2013
)
0.82
"Despite considerable interest in the physiologic effects of isoflavones, the in vivo bioavailability of the most common isoflavone forms, malonylglucoside conjugates, has not been determined."( Malonylglucoside conjugates of isoflavones are much less bioavailable compared with unconjugated β-glucosidic forms in rats.
Gallaher, DD; Ismail, B; Yerramsetty, V, 2014
)
0.4
" The aim of this study was to investigate the effect of a fixed combination of soy isoflavones on the oral bioavailability of levothyroxine in post-menopausal female volunteers."( Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers.
Barbetta, B; Benvenuti, C; Colovic, M; Donazzolo, Y; Giacovelli, G; Manzotti, C; Persiani, S; Rovati, LC; Sala, F; Vitalini, C; Zangarini, M, 2016
)
0.43
"Daidzein, which is scarce in nature, has gained significant attention due to its superior biological activity and bioavailability compared with daidzin."( Highly Efficient Enzymatic Preparation of Daidzein in Deep Eutectic Solvents.
Cheng, QB; Zhang, LW, 2017
)
0.66
" Validation of potential health benefits of functional foods requires information about the bioavailability and metabolism of bioactive compounds."( A major daidzin metabolite 7,8,4'-trihydroxyisoflavone found in the plasma of soybean extract-fed rats attenuates monocyte-endothelial cell adhesion.
Desjardins, Y; Dubé, P; Dudonné, S; Kim, JE; Kim, JH; Kim, JS; Lee, CC; Lee, CY; Lee, KW; Park, JHY, 2018
)
0.92
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
hydroxyisoflavoneMember of the class of isoflavones bearing at least one hydroxy group.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
7-hydroxyisoflavones 7-O-beta-D-glucosideA glycosyloxyisoflavone that is any 7-hydroxyisoflavone compound in which the 7-hydroxy group has been converted into its corresponding O-beta-D-glucoside.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
daidzein conjugates interconversion017
daidzin and daidzein degradation311

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
PPM1D proteinHomo sapiens (human)Potency16.53880.00529.466132.9993AID1347411
Interferon betaHomo sapiens (human)Potency16.53880.00339.158239.8107AID1347411
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Aldehyde Dehydrogenase, MitochondrialHomo sapiens (human)IC50 (µMol)0.08000.08000.08000.0800AID977608
Retinal dehydrogenase 2Homo sapiens (human)IC50 (µMol)4.50004.50004.50004.5000AID1441743
Retinal dehydrogenase 1Homo sapiens (human)IC50 (µMol)200.00000.02001.04766.7900AID1441741
Aldehyde dehydrogenase, mitochondrialHomo sapiens (human)IC50 (µMol)1.20670.04003.40799.0000AID1441738; AID31427; AID34047
Aldehyde dehydrogenase X, mitochondrialHomo sapiens (human)IC50 (µMol)5.10005.10005.10005.1000AID1441739
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Interleukin-2Homo sapiens (human)Kd3.38000.00001.30375.4700AID1156797
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (127)

Processvia Protein(s)Taxonomy
blood vessel developmentRetinal dehydrogenase 2Homo sapiens (human)
kidney developmentRetinal dehydrogenase 2Homo sapiens (human)
liver developmentRetinal dehydrogenase 2Homo sapiens (human)
retinoic acid biosynthetic processRetinal dehydrogenase 2Homo sapiens (human)
heart morphogenesisRetinal dehydrogenase 2Homo sapiens (human)
vitamin A metabolic processRetinal dehydrogenase 2Homo sapiens (human)
midgut developmentRetinal dehydrogenase 2Homo sapiens (human)
cell population proliferationRetinal dehydrogenase 2Homo sapiens (human)
positive regulation of cell population proliferationRetinal dehydrogenase 2Homo sapiens (human)
negative regulation of cell population proliferationRetinal dehydrogenase 2Homo sapiens (human)
determination of bilateral symmetryRetinal dehydrogenase 2Homo sapiens (human)
proximal/distal pattern formationRetinal dehydrogenase 2Homo sapiens (human)
positive regulation of gene expressionRetinal dehydrogenase 2Homo sapiens (human)
neural crest cell developmentRetinal dehydrogenase 2Homo sapiens (human)
morphogenesis of embryonic epitheliumRetinal dehydrogenase 2Homo sapiens (human)
neural tube developmentRetinal dehydrogenase 2Homo sapiens (human)
pituitary gland developmentRetinal dehydrogenase 2Homo sapiens (human)
neuron differentiationRetinal dehydrogenase 2Homo sapiens (human)
lung developmentRetinal dehydrogenase 2Homo sapiens (human)
hindbrain developmentRetinal dehydrogenase 2Homo sapiens (human)
pancreas developmentRetinal dehydrogenase 2Homo sapiens (human)
embryonic camera-type eye developmentRetinal dehydrogenase 2Homo sapiens (human)
response to estradiolRetinal dehydrogenase 2Homo sapiens (human)
response to retinoic acidRetinal dehydrogenase 2Homo sapiens (human)
response to vitamin ARetinal dehydrogenase 2Homo sapiens (human)
response to cytokineRetinal dehydrogenase 2Homo sapiens (human)
embryonic forelimb morphogenesisRetinal dehydrogenase 2Homo sapiens (human)
ureter maturationRetinal dehydrogenase 2Homo sapiens (human)
retinol metabolic processRetinal dehydrogenase 2Homo sapiens (human)
retinoic acid metabolic processRetinal dehydrogenase 2Homo sapiens (human)
retinal metabolic processRetinal dehydrogenase 2Homo sapiens (human)
9-cis-retinoic acid biosynthetic processRetinal dehydrogenase 2Homo sapiens (human)
positive regulation of apoptotic processRetinal dehydrogenase 2Homo sapiens (human)
embryonic digestive tract developmentRetinal dehydrogenase 2Homo sapiens (human)
cardiac muscle tissue developmentRetinal dehydrogenase 2Homo sapiens (human)
protein homotetramerizationRetinal dehydrogenase 2Homo sapiens (human)
face developmentRetinal dehydrogenase 2Homo sapiens (human)
cellular response to retinoic acidRetinal dehydrogenase 2Homo sapiens (human)
retinoic acid receptor signaling pathway involved in somitogenesisRetinal dehydrogenase 2Homo sapiens (human)
regulation of vascular endothelial cell proliferationRetinal dehydrogenase 2Homo sapiens (human)
retinoid metabolic processRetinal dehydrogenase 1Homo sapiens (human)
cellular aldehyde metabolic processRetinal dehydrogenase 1Homo sapiens (human)
gamma-aminobutyric acid biosynthetic processRetinal dehydrogenase 1Homo sapiens (human)
fructosamine catabolic processRetinal dehydrogenase 1Homo sapiens (human)
maintenance of lens transparencyRetinal dehydrogenase 1Homo sapiens (human)
retinol metabolic processRetinal dehydrogenase 1Homo sapiens (human)
cellular detoxification of aldehydeRetinal dehydrogenase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisRetinal dehydrogenase 1Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
carbohydrate metabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
alcohol metabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
ethanol catabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde catabolic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
regulation of dopamine biosynthetic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
regulation of serotonin biosynthetic processAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
carbohydrate metabolic processAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
ethanol catabolic processAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
optic cup morphogenesis involved in camera-type eye developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
retinoic acid biosynthetic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
apoptotic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
locomotory behaviorAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
nucleus accumbens developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
embryonic camera-type eye developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
inner ear morphogenesisAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
retinol metabolic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
retinoic acid metabolic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
retinal metabolic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
positive regulation of apoptotic processAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
embryonic eye morphogenesisAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
neuromuscular process controlling balanceAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
protein homotetramerizationAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
righting reflexAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
olfactory pit developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
face developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
Harderian gland developmentAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
positive regulation of immunoglobulin productionInterleukin-2Homo sapiens (human)
positive regulation of plasma cell differentiationInterleukin-2Homo sapiens (human)
negative regulation of B cell apoptotic processInterleukin-2Homo sapiens (human)
positive regulation of B cell proliferationInterleukin-2Homo sapiens (human)
positive regulation of activated T cell proliferationInterleukin-2Homo sapiens (human)
negative regulation of protein phosphorylationInterleukin-2Homo sapiens (human)
adaptive immune responseInterleukin-2Homo sapiens (human)
leukocyte activation involved in immune responseInterleukin-2Homo sapiens (human)
transcription by RNA polymerase IIInterleukin-2Homo sapiens (human)
immune responseInterleukin-2Homo sapiens (human)
cell adhesionInterleukin-2Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationInterleukin-2Homo sapiens (human)
protein kinase C-activating G protein-coupled receptor signaling pathwayInterleukin-2Homo sapiens (human)
cell-cell signalingInterleukin-2Homo sapiens (human)
positive regulation of cell population proliferationInterleukin-2Homo sapiens (human)
natural killer cell activationInterleukin-2Homo sapiens (human)
T cell differentiationInterleukin-2Homo sapiens (human)
positive regulation of cell growthInterleukin-2Homo sapiens (human)
positive regulation of type II interferon productionInterleukin-2Homo sapiens (human)
positive regulation of interleukin-17 productionInterleukin-2Homo sapiens (human)
positive regulation of tissue remodelingInterleukin-2Homo sapiens (human)
interleukin-2-mediated signaling pathwayInterleukin-2Homo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinInterleukin-2Homo sapiens (human)
negative regulation of apoptotic processInterleukin-2Homo sapiens (human)
response to ethanolInterleukin-2Homo sapiens (human)
positive regulation of regulatory T cell differentiationInterleukin-2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterleukin-2Homo sapiens (human)
regulation of T cell homeostatic proliferationInterleukin-2Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesInterleukin-2Homo sapiens (human)
negative regulation of lymphocyte proliferationInterleukin-2Homo sapiens (human)
negative regulation of inflammatory responseInterleukin-2Homo sapiens (human)
positive regulation of inflammatory responseInterleukin-2Homo sapiens (human)
activated T cell proliferationInterleukin-2Homo sapiens (human)
positive regulation of dendritic spine developmentInterleukin-2Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandInterleukin-2Homo sapiens (human)
response to tacrolimusInterleukin-2Homo sapiens (human)
negative regulation of T-helper 17 cell differentiationInterleukin-2Homo sapiens (human)
regulation of CD4-positive, alpha-beta T cell proliferationInterleukin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (30)

Processvia Protein(s)Taxonomy
retinal dehydrogenase activityRetinal dehydrogenase 2Homo sapiens (human)
3-chloroallyl aldehyde dehydrogenase activityRetinal dehydrogenase 2Homo sapiens (human)
retinal bindingRetinal dehydrogenase 2Homo sapiens (human)
aldehyde dehydrogenase (NAD+) activityRetinal dehydrogenase 2Homo sapiens (human)
retinal dehydrogenase activityRetinal dehydrogenase 1Homo sapiens (human)
aldehyde dehydrogenase (NAD+) activityRetinal dehydrogenase 1Homo sapiens (human)
GTPase activator activityRetinal dehydrogenase 1Homo sapiens (human)
androgen bindingRetinal dehydrogenase 1Homo sapiens (human)
protein bindingRetinal dehydrogenase 1Homo sapiens (human)
aminobutyraldehyde dehydrogenase activityRetinal dehydrogenase 1Homo sapiens (human)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activityRetinal dehydrogenase 1Homo sapiens (human)
NAD bindingRetinal dehydrogenase 1Homo sapiens (human)
3-deoxyglucosone dehydrogenase activityRetinal dehydrogenase 1Homo sapiens (human)
benzaldehyde dehydrogenase (NAD+) activityRetinal dehydrogenase 1Homo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
aldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
aldehyde dehydrogenase [NAD(P)+] activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
phenylacetaldehyde dehydrogenase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
electron transfer activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
nitroglycerin reductase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
NAD bindingAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
carboxylesterase activityAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activityAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
NAD bindingAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
aldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
retinal dehydrogenase activityAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
aldehyde dehydrogenase [NAD(P)+] activityAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
protein homodimerization activityAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
thyroid hormone bindingAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
NAD+ bindingAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
aldehyde dehydrogenase (NAD+) activityAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
cytokine activityInterleukin-2Homo sapiens (human)
interleukin-2 receptor bindingInterleukin-2Homo sapiens (human)
protein bindingInterleukin-2Homo sapiens (human)
growth factor activityInterleukin-2Homo sapiens (human)
kinase activator activityInterleukin-2Homo sapiens (human)
carbohydrate bindingInterleukin-2Homo sapiens (human)
kappa-type opioid receptor bindingInterleukin-2Homo sapiens (human)
glycosphingolipid bindingInterleukin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
cytoplasmRetinal dehydrogenase 2Homo sapiens (human)
cytosolRetinal dehydrogenase 2Homo sapiens (human)
perinuclear region of cytoplasmRetinal dehydrogenase 2Homo sapiens (human)
cytoplasmRetinal dehydrogenase 1Homo sapiens (human)
cytosolRetinal dehydrogenase 1Homo sapiens (human)
axonRetinal dehydrogenase 1Homo sapiens (human)
synapseRetinal dehydrogenase 1Homo sapiens (human)
extracellular exosomeRetinal dehydrogenase 1Homo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
mitochondrionAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
mitochondrial matrixAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
extracellular exosomeAldehyde dehydrogenase, mitochondrialHomo sapiens (human)
nucleoplasmAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
mitochondrionAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
mitochondrial matrixAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
cytosolAldehyde dehydrogenase X, mitochondrialHomo sapiens (human)
cytoplasmAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
cytosolAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
extracellular exosomeAldehyde dehydrogenase family 1 member A3Homo sapiens (human)
extracellular spaceInterleukin-2Homo sapiens (human)
extracellular regionInterleukin-2Homo sapiens (human)
extracellular spaceInterleukin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (80)

Assay IDTitleYearJournalArticle
AID1441739Inhibition of full length recombinant human ALDH1B1 expressed in Escherichia coli TunerDE3 assessed as reduction in dehydrogenase activity by measuring NAD(P)H level preincubated for 2 mins followed by addition of propionaldehyde as substrate in presence
AID1850971Binding affinity to human telomeric IKF1 G4 quadruplex DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID456316ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1213824Drug metabolism in Wistar rat plasma assessed as retention time by HPLC-DAD analysis2012Drug metabolism and disposition: the biological fate of chemicals, Nov, Volume: 40, Issue:11
Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats.
AID84344Accumulation of 5 HIAL in isolated Hamster Liver Mitochondria at 0.9 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1428455Renoprotective activity in pig LLC-PK1 cells assessed as inhibition of cisplatin-induced damage by measuring cell viability up to 100 uM preincubated for 24 hrs followed by addition of Ez-Cytox reagent and measured after 2 hrs relative to control2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID671762Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1441765Selectivity ratio of IC50 for full length recombinant human ALDH1A1 expressed in Escherichia coli BL21(DE3) to IC50 for full length recombinant human ALDH2 expressed in Escherichia coli
AID341733Inhibition of hamster liver ALDH22008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase.
AID1213827Drug recovery in Wistar rat plasma at 2000 ng/ml by HPLC-DAD analysis2012Drug metabolism and disposition: the biological fate of chemicals, Nov, Volume: 40, Issue:11
Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats.
AID1447213Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate at 0.0625 mg/mL preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID84188Inhibition of 5-HIAA formation in isolated Hamster Liver Mitochondria at 0.3 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID30974Evaluated for time required to reach maximum concentration in plasma2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1850984Displacement of thiazole orange from human ILPR G4 quadruplex DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1156795Retention time of the compound by chromatography2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1850989Displacement of thiazole orange from human ILPR i-motif DNA at 100 equiv. at pH 5.5 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850987Displacement of thiazole orange from human ILPR i-motif DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850985Displacement of thiazole orange from human ILPR G4 quadruplex DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID31427Inhibition of Hamster Liver mitochondrial ALDH-22000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID84190Inhibition of 5-HIAA formation in isolated Hamster Liver Mitochondria at 3 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID671761Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID125225Inhibition of hamster liver mitochondrial monoamine oxidase MAO2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID456319ABTS radical scavenging activity assessed as vitamin C equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1447210Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate at 0.5 mg/mL preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID493896Glucose uptake enhancing activity in insulin-stimulated mouse 3T3L1 cells at 10 uM after 4 days by FLIPR based 2-DG uptake assay relative to control2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Glucose uptake enhancing activity of puerarin and the role of C-glucoside suggested from activity of related compounds.
AID1850978Displacement of thiazole orange from human telomeric IKF1 G4 quadruplex DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1441741Inhibition of full length recombinant human ALDH1A1 expressed in Escherichia coli BL21(DE3) assessed as reduction in dehydrogenase activity by measuring NAD(P)H level preincubated for 2 mins followed by addition of propionaldehyde as substrate in presence
AID1850976Binding affinity to human ILPR i-motif DNA assessed as change in melting temperature at 20 uM at pH 5.5 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1850982Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 10 equiv. at pH 5.5 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850974Binding affinity to human ILPR G4 quadruplex DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1204996Inhibition of Saccharomyces cerevisiae alpha-glucosidase type 1 assessed as 4-nitrophenol cleavage product by high-resolution biochromatogram2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
AID34047Inhibition of hamster liver aldehyde dehydrogenase ALDH-22001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID1156797Binding affinity to IL-2 (unknown origin)2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1850979Displacement of thiazole orange from human telomeric IKF1 G4 quadruplex DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID1204997Antioxidant activity of the compound assessed as inhibition of ABTS radicals after 20 mins by spectrophotometric analysis2015Journal of natural products, Feb-27, Volume: 78, Issue:2
Dual high-resolution α-glucosidase and radical scavenging profiling combined with HPLC-HRMS-SPE-NMR for identification of minor and major constituents directly from the crude extract of Pueraria lobata.
AID1441745Inhibition of full length recombinant human ALDH1A3 expressed in Escherichia coli BL21(DE3) assessed as reduction in dehydrogenase activity by measuring NAD(P)H level preincubated for 2 mins followed by addition of propionaldehyde as substrate in presence
AID1850975Binding affinity to human ILPR i-motif DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1441746Inhibition of rat ALDH1L1 assessed as reduction in dehydrogenase activity by measuring NAD(P)H level preincubated for 2 mins followed by addition of propionaldehyde as substrate in presence of NAD+ by spectrophotometric method
AID1850990Displacement of thiazole orange from human 1BNA double stranded DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID671764Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA2012Bioorganic & medicinal chemistry letters, Jun-15, Volume: 22, Issue:12
Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13.
AID1428454Antibacterial activity against Staphylococcus aureus NCTC 8325-4 by EUCAST method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID1441738Inhibition of full length recombinant human ALDH2 expressed in Escherichia coli assessed as reduction in dehydrogenase activity by measuring NAD(P)H level preincubated for 2 mins followed by addition of propionaldehyde as substrate in presence of NAD+ by
AID1850972Binding affinity to human telomeric 1ELN i-motif DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850991Displacement of thiazole orange from human 1BNA double stranded DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID84191Inhibition of 5-HIAA formation in isolated Hamster Liver Mitochondria at 9 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1447212Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate at 0.125 mg/mL preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID1447211Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate at 0.25 mg/mL preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID84343Accumulation of 5 HIAL in isolated Hamster Liver Mitochondria at 0.3 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID456318DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID400607Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression at 10 uM after 18 hrs measured as microunits of tissue factor/10'5 cells1996Journal of natural products, Mar, Volume: 59, Issue:3
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1441747Inhibition of full length recombinant human ALDH3A1 expressed in Escherichia coli BL21(DE3) assessed as reduction in dehydrogenase activity by measuring NAD(P)H level preincubated for 2 mins followed by addition of benzaldehyde as substrate in presence of
AID125223Compound was evaluated for the inhibition of Hamster Liver mitochondrial Monoamine oxidase; No inhibition2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID87108Suppression of Hamster ethanol intake by 0.07 mmol o.d. i.p.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID84345Accumulation of 5 HIAL in isolated Hamster Liver Mitochondria at 3 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1850986Displacement of thiazole orange from human ILPR i-motif DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1441743Inhibition of full length recombinant human ALDH1A2 expressed in Escherichia coli BL21(DE3) assessed as reduction in dehydrogenase activity by measuring NAD(P)H level preincubated for 2 mins followed by addition of propionaldehyde as substrate in presence
AID84189Inhibition of 5-HIAA formation in isolated Hamster Liver Mitochondria at 0.9 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1447219Inhibition of alpha glucosidase (unknown origin) using alpha PNPG as substrate preincubated for 15 mins followed by substrate addition measured after 15 mins2017Bioorganic & medicinal chemistry letters, 05-01, Volume: 27, Issue:9
Constituents with potent α-glucosidase inhibitory activity from Pueraria lobata (Willd.) ohwi.
AID1850981Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 100 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1428453Antibacterial activity against Escherichia coli DH10B by EUCAST method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID11154Evaluated for Pharmacokinetic property: Area under the curve2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1850980Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 10 equiv. at pH 7.4 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850973Binding affinity to human telomeric 1ELN i-motif DNA assessed as change in melting temperature at 20 uM at pH 5.5 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1180339Antioxidant activity assessed as AAPH-induced peroxyl radical scavenging activity by oxygen radical absorbance assay2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Anti-osteoporotic and antioxidant activities of chemical constituents of the aerial parts of Ducrosia ismaelis.
AID1156799Anticancer activity against human HepG2 cells assessed as cell viability after 24 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1428452Antifungal activity against Cryptococcus neoformans H99 by CLSI M27-A3 broth microdilution method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID1850988Displacement of thiazole orange from human ILPR i-motif DNA at 10 equiv. at pH 5.5 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1428451Antifungal activity against Candida albicans SC5314 by CLSI M27-A3 broth microdilution method2016Journal of natural products, Dec-23, Volume: 79, Issue:12
Termisoflavones A-C, Isoflavonoid Glycosides from Termite-Associated Streptomyces sp. RB1.
AID84346Accumulation of 5 HIAL in isolated Hamster Liver Mitochondria at 9 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1180340Antioxidant activity assessed as AAPH-induced peroxyl radical scavenging activity at 10 uM by oxygen radical absorbance assay relative to trolox2014Bioorganic & medicinal chemistry letters, Aug-01, Volume: 24, Issue:15
Anti-osteoporotic and antioxidant activities of chemical constituents of the aerial parts of Ducrosia ismaelis.
AID1850983Displacement of thiazole orange from human telomeric 1ELN i-motif DNA at 100 equiv. at pH 5.5 by fluorescent intercalator displacement assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1850977Binding affinity to human 1BNA double stranded DNA assessed as change in melting temperature at 20 uM at pH 7.4 by FRET assay2022Bioorganic & medicinal chemistry letters, 10-01, Volume: 73Identification of sugar-containing natural products that interact with i-motif DNA.
AID1745854NCATS anti-infectives library activity on HEK293 viability as a counter-qHTS vs the C. elegans viability qHTS2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1745855NCATS anti-infectives library activity on the primary C. elegans qHTS viability assay2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (206)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (2.43)18.7374
1990's27 (13.11)18.2507
2000's59 (28.64)29.6817
2010's96 (46.60)24.3611
2020's19 (9.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.61 (24.57)
Research Supply Index5.45 (2.92)
Research Growth Index5.32 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (2.65%)5.53%
Reviews4 (1.77%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other216 (95.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Human Pharmacology Study to Evaluate the Interaction Between a Natural Inhibitor of Aldehyde Dehydrogenase 2 (ALDH2) and Alcohol in Healthy Volunteers. Pilot Clinical Trial [NCT02309801]Phase 110 participants (Actual)Interventional2012-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]